Summary
Boston Scientific Corporation (BSX) has announced the successful completion of its acquisition of Apama Medical, Inc., which closed on October 10, 2017. This strategic move, first announced on October 2, 2017, is expected to have an impact on the company's earnings per share, as indicated in their forward-looking statements. Investors should note that the details of the transaction, including specific financial terms, are not disclosed in this particular 8-K filing, but a press release (Exhibit 99.1) provides further information regarding the signing of the definitive agreement. The company's management has included a standard cautionary statement regarding forward-looking statements. This highlights that actual results may differ materially from projections due to various risks and uncertainties. Investors are advised to consult BSX's most recent Annual Report (10-K) and subsequent Quarterly Reports (10-Q) for a comprehensive understanding of these potential risks.
Key Highlights
- 1Boston Scientific (BSX) has completed the acquisition of Apama Medical, Inc.
- 2The acquisition closed on October 10, 2017.
- 3The definitive agreement for the acquisition was signed on October 2, 2017.
- 4The company expects the acquisition to impact its earnings per share.
- 5Further details on the transaction are available in the press release filed as Exhibit 99.1.
- 6The filing includes a cautionary statement regarding forward-looking statements and potential risks.
- 7Investors are directed to review BSX's 10-K and 10-Q filings for risk factor details.